BIOLIFE SOLUTIONS INC (BLFS) Stock Analyst Earnings Estimates
NASDAQ:BLFS - Nasdaq - US09062W2044 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 119.2M 147.82% | 161.8M 35.74% | 143.271M -11.45% | 109.24M -23.75% | 98.016M -10.27% | 125.28M 27.82% | 191.13M 52.56% | 210.94M 10.36% | 272.86M 29.35% | 352.08M 29.03% | 451.41M 28.21% | 574.14M 27.19% | |
| EBITDA YoY % growth | -20.64M -4,700.00% | -18.62M 9.79% | -43.045M -131.18% | 16.843M 139.13% | 26.126M 55.11% | 41.868M 60.25% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.5M -509.09% | -35.1M -4.78% | -55.34M -57.66% | -10.655M 80.75% | -8.967M 15.84% | 6.09M 167.92% | 19.922M 227.13% | 30.989M 55.55% | 50.573M 63.20% | 79.652M 57.50% | 121.07M 52.00% | 175.79M 45.20% | |
| Operating Margin | -28.10% | -21.69% | -38.63% | -9.75% | -9.15% | 4.86% | 10.42% | 14.69% | 18.53% | 22.62% | 26.82% | 30.62% | |
| EPS YoY % growth | -0.52 38.82% | -1.61 -209.62% | -1.15 28.57% | -0.81 29.49% | -0.21 74.21% | 0.07 132.52% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 78.14% | -0.06 73.39% | -0.05 90.31% | -0.04 4.38% | -0.04 41.67% | 0.01 116.67% | 0.02 142.11% | 0.02 153.33% | 0.04 206.67% |
| Revenue Q2Q % growth | 21.978M -32.85% | 22.266M -29.82% | 23.719M -16.27% | 25.504M -16.57% | 26.74M 21.67% | 33.189M 49.06% | 34.631M 46.01% | 37.518M 47.11% | 38.96M 45.70% |
| EBITDA Q2Q % growth | 4.112M 578.14% | 4.592M 343.87% | 5.61M 204.07% | 6.593M 22.14% | 6.874M 67.17% | 9.482M 106.49% | 10.374M 84.92% | 10.779M 63.49% | 11.569M 68.30% |
| EBIT Q2Q % growth | -3.121M 76.27% | -2.206M 46.99% | -1.493M 46.57% | -660.96K 57.60% | -512.723K 83.57% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.04 86.67% | -0.09 | 0.05 | 55.00% |
| Q2 2024 Q2Q % growth | -0.50 -117.39% | -0.14 | -0.36 | -246.60% |
| Q1 2024 Q2Q % growth | -0.23 28.13% | -0.29 | 0.06 | 19.47% |
| Q4 2023 Q2Q % growth | -0.30 73.91% | -0.35 | 0.05 | 13.92% |
| Q3 2023 Q2Q % growth | -0.30 -30.43% | -0.38 | 0.08 | 21.57% |
| Q2 2023 Q2Q % growth | -0.23 -283.33% | -0.20 | -0.03 | -12.75% |
| Q1 2023 Q2Q % growth | -0.32 -88.24% | -0.22 | -0.10 | -48.38% |
| Q4 2022 Q2Q % growth | -1.15 -210.81% | -0.17 | -0.98 | -576.46% |
| Q3 2022 Q2Q % growth | -0.23 | -0.17 | -0.06 | -32.64% |
| Q2 2022 Q2Q % growth | -0.06 50.00% | -0.22 | 0.16 | 72.55% |
| Q1 2022 Q2Q % growth | -0.17 -466.67% | -0.25 | 0.08 | 32.43% |
| Q4 2021 Q2Q % growth | -0.37 -516.67% | -0.17 | -0.20 | -115.19% |
| Q3 2021 Q2Q % growth | 0.00 100.00% | -0.09 | 0.09 | 100.00% |
| Q2 2021 Q2Q % growth | -0.12 82.86% | -0.07 | -0.05 | -76.46% |
| Q1 2021 Q2Q % growth | -0.03 -200.00% | -0.04 | 0.01 | 23.27% |
| Q4 2020 Q2Q % growth | -0.06 -400.00% | -0.02 | -0.04 | -174.49% |
| Q3 2020 Q2Q % growth | -0.08 -166.67% | -0.02 | -0.06 | -327.89% |
| Q2 2020 Q2Q % growth | -0.70 -1,850.00% | -0.04 | -0.66 | -1,860.78% |
| Q1 2020 Q2Q % growth | -0.01 -133.33% | -0.02 | 0.01 | 39.67% |
| Q4 2019 Q2Q % growth | 0.02 | -0.02 | 0.04 | 203.80% |
| Q3 2019 Q2Q % growth | -0.03 | 0.02 | -0.05 | -226.07% |
| Q2 2019 Q2Q % growth | 0.04 | 0.02 | 0.02 | 63.40% |
| Q1 2019 Q2Q % growth | 0.03 | 0.04 | -0.01 | -26.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 30.571M -8.27% | 26.048M | 4.523M | 17.36% |
| Q2 2024 Q2Q % growth | 28.328M -28.30% | 24.425M | 3.903M | 15.98% |
| Q1 2024 Q2Q % growth | 31.727M -15.85% | 26.527M | 5.2M | 19.60% |
| Q4 2023 Q2Q % growth | 32.732M -26.05% | 34.067M | -1.335M | -3.92% |
| Q3 2023 Q2Q % growth | 33.328M -18.21% | 33.668M | -340K | -1.01% |
| Q2 2023 Q2Q % growth | 39.508M -2.52% | 44.737M | -5.229M | -11.69% |
| Q1 2023 Q2Q % growth | 37.703M 4.09% | 43.802M | -6.099M | -13.92% |
| Q4 2022 Q2Q % growth | 44.26M 18.63% | 44.151M | 109K | 0.25% |
| Q3 2022 Q2Q % growth | 40.75M 20.56% | 42.905M | -2.155M | -5.02% |
| Q2 2022 Q2Q % growth | 40.53M 29.90% | 39.965M | 565K | 1.41% |
| Q1 2022 Q2Q % growth | 36.22M 114.96% | 38.968M | -2.748M | -7.05% |
| Q4 2021 Q2Q % growth | 37.31M 153.29% | 36.53M | 780K | 2.14% |
| Q3 2021 Q2Q % growth | 33.8M 199.65% | 32.242M | 1.558M | 4.83% |
| Q2 2021 Q2Q % growth | 31.2M 214.52% | 28.104M | 3.096M | 11.02% |
| Q1 2021 Q2Q % growth | 16.85M 38.57% | 16.37M | 480K | 2.93% |
| Q4 2020 Q2Q % growth | 14.73M 77.47% | 13.767M | 963K | 6.99% |
| Q3 2020 Q2Q % growth | 11.28M 70.91% | 11.034M | 246K | 2.23% |
| Q2 2020 Q2Q % growth | 9.92M 48.06% | 9.76M | 160K | 1.64% |
| Q1 2020 Q2Q % growth | 12.16M 110.75% | 10.921M | 1.239M | 11.35% |
| Q4 2019 Q2Q % growth | 8.3M | 9.193M | -893K | -9.71% |
| Q3 2019 Q2Q % growth | 6.6M | 7.781M | -1.181M | -15.18% |
| Q2 2019 Q2Q % growth | 6.7M | 6.888M | -188K | -2.73% |
| Q1 2019 Q2Q % growth | 5.77M | 6.039M | -269K | -4.45% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 33.5% | -4.25% | 9.66% | -43.24% |
| Revenue | -5.39% | -9.41% | 0% | -3.15% |